SlideShare una empresa de Scribd logo
1 de 30
Issues in Selection of Deltas in Non-Inferiority Trials  : Acute Bacterial  Meningitis and Hospital-Acquired Pneumonia dr shabeel pn www.hi-dentfinishingschool.blogspot.com
Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-Inferiority Trials ,[object Object],[object Object],[object Object],[object Object],[object Object]
Non-Inferiority Margins ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],-20% +20% -8% -15%
Components of Delta ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Delta -  Delta 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Delta -  Delta 2 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Delta -  various diseases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Delta Meningitis and HAP ,[object Object],[object Object],[object Object],[object Object]
Components of Delta Meningitis and HAP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Historical Data - Meningitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Historical Data - Meningitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Historical Data - HAP ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Historical Data - HAP
Historical Data - HAP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Delta Meningitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Delta HAP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Delta Meningitis and HAP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Consequences of Failure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Practical Issues ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trial Implications: Sample size per arm to achieve 80% power 
Epidemiology of Meningitis* *Based on 248 cases in 1995 from Schuchat et al. N Engl J Med. 1997;337:970-6.
Epidemiology of Meningitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Epidemiology of HAP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Recent Trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trial Implications: Sample size per arm to achieve 80% power 
Components of Delta Meningitis and HAP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Balance ,[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

nosocomial pneumonia
nosocomial pneumonianosocomial pneumonia
nosocomial pneumonia
shabeel pn
 
Diagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfDiagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdf
usapuka
 
JAMA_Poordad et al 2015
JAMA_Poordad et al 2015JAMA_Poordad et al 2015
JAMA_Poordad et al 2015
Eric A. Hughes
 

La actualidad más candente (20)

Biomarker Discovery For Early Clin Dev Dublin Oct 2008
Biomarker Discovery For Early Clin Dev   Dublin Oct 2008Biomarker Discovery For Early Clin Dev   Dublin Oct 2008
Biomarker Discovery For Early Clin Dev Dublin Oct 2008
 
Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19Remdesivir for the Treatment of Covid-19
Remdesivir for the Treatment of Covid-19
 
Antibiotic de escalation_in_the_icu___how_is_it.
Antibiotic de escalation_in_the_icu___how_is_it.Antibiotic de escalation_in_the_icu___how_is_it.
Antibiotic de escalation_in_the_icu___how_is_it.
 
Atb y resistencia en neumonias virales
Atb y resistencia en neumonias viralesAtb y resistencia en neumonias virales
Atb y resistencia en neumonias virales
 
Clinical perspectives on_echinocandin_resistance
Clinical perspectives on_echinocandin_resistanceClinical perspectives on_echinocandin_resistance
Clinical perspectives on_echinocandin_resistance
 
Clin infect dis. 2016-cao-250-7
Clin infect dis. 2016-cao-250-7Clin infect dis. 2016-cao-250-7
Clin infect dis. 2016-cao-250-7
 
Ats neumonia
Ats neumoniaAts neumonia
Ats neumonia
 
Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)
 
Susan Ellenberg, Evaluating Treatments in Settings Demanding Urgency: Lessons...
Susan Ellenberg, Evaluating Treatments in Settings Demanding Urgency: Lessons...Susan Ellenberg, Evaluating Treatments in Settings Demanding Urgency: Lessons...
Susan Ellenberg, Evaluating Treatments in Settings Demanding Urgency: Lessons...
 
2015 10-06 Building Bridges Biomarker symposium FIMM Helsinki, Alain van Gool
2015 10-06 Building Bridges Biomarker symposium FIMM Helsinki, Alain van Gool2015 10-06 Building Bridges Biomarker symposium FIMM Helsinki, Alain van Gool
2015 10-06 Building Bridges Biomarker symposium FIMM Helsinki, Alain van Gool
 
nosocomial pneumonia
nosocomial pneumonianosocomial pneumonia
nosocomial pneumonia
 
Tto tbc nejm
Tto tbc nejmTto tbc nejm
Tto tbc nejm
 
Necessity of COVID-19 vaccination in previously infected individuals
Necessity of COVID-19 vaccination in previously infected individualsNecessity of COVID-19 vaccination in previously infected individuals
Necessity of COVID-19 vaccination in previously infected individuals
 
Diagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfDiagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdf
 
Sepsis and antibiotic guidance in neurology wards
Sepsis and antibiotic guidance in neurology wardsSepsis and antibiotic guidance in neurology wards
Sepsis and antibiotic guidance in neurology wards
 
The story of personalized medicine
The story of personalized medicineThe story of personalized medicine
The story of personalized medicine
 
A Clinical Prediction Rule for Fluoroquinolone Resistance 3 14 11
A Clinical Prediction Rule for Fluoroquinolone Resistance 3 14 11A Clinical Prediction Rule for Fluoroquinolone Resistance 3 14 11
A Clinical Prediction Rule for Fluoroquinolone Resistance 3 14 11
 
10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)
 
Bacterial meningitis
Bacterial meningitisBacterial meningitis
Bacterial meningitis
 
JAMA_Poordad et al 2015
JAMA_Poordad et al 2015JAMA_Poordad et al 2015
JAMA_Poordad et al 2015
 

Destacado

Electrolytes Disturbances
Electrolytes DisturbancesElectrolytes Disturbances
Electrolytes Disturbances
shabeel pn
 
Heart 2003 Opt
Heart 2003 OptHeart 2003 Opt
Heart 2003 Opt
shabeel pn
 
Antibiotic Resistanace
Antibiotic ResistanaceAntibiotic Resistanace
Antibiotic Resistanace
shabeel pn
 
Dexmedetomidine For Pediatric Procedural Sedation
Dexmedetomidine For Pediatric Procedural SedationDexmedetomidine For Pediatric Procedural Sedation
Dexmedetomidine For Pediatric Procedural Sedation
shabeel pn
 
Contrast Agents In Radiology
Contrast Agents In RadiologyContrast Agents In Radiology
Contrast Agents In Radiology
shabeel pn
 
When to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment StudyWhen to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment Study
shabeel pn
 
Endodontic Emergencies
Endodontic  EmergenciesEndodontic  Emergencies
Endodontic Emergencies
shabeel pn
 
Smokeless Tobacco & Oral Cancer New
Smokeless Tobacco & Oral Cancer  NewSmokeless Tobacco & Oral Cancer  New
Smokeless Tobacco & Oral Cancer New
shabeel pn
 
Postoperative Complications
Postoperative ComplicationsPostoperative Complications
Postoperative Complications
shabeel pn
 
pre prosthetic mouth preparation
pre prosthetic mouth preparationpre prosthetic mouth preparation
pre prosthetic mouth preparation
shabeel pn
 
Antiarrythmics
AntiarrythmicsAntiarrythmics
Antiarrythmics
shabeel pn
 
anchorage in orthodontics
anchorage in orthodonticsanchorage in orthodontics
anchorage in orthodontics
shabeel pn
 
salivary gland diseases
salivary gland diseasessalivary gland diseases
salivary gland diseases
shabeel pn
 
Sedative-Hypnotic Drugs
Sedative-Hypnotic DrugsSedative-Hypnotic Drugs
Sedative-Hypnotic Drugs
shabeel pn
 

Destacado (19)

Electrolytes Disturbances
Electrolytes DisturbancesElectrolytes Disturbances
Electrolytes Disturbances
 
Heart 2003 Opt
Heart 2003 OptHeart 2003 Opt
Heart 2003 Opt
 
Antibiotic Resistanace
Antibiotic ResistanaceAntibiotic Resistanace
Antibiotic Resistanace
 
Immunesystem
ImmunesystemImmunesystem
Immunesystem
 
Dexmedetomidine For Pediatric Procedural Sedation
Dexmedetomidine For Pediatric Procedural SedationDexmedetomidine For Pediatric Procedural Sedation
Dexmedetomidine For Pediatric Procedural Sedation
 
Parathyroids
ParathyroidsParathyroids
Parathyroids
 
Contrast Agents In Radiology
Contrast Agents In RadiologyContrast Agents In Radiology
Contrast Agents In Radiology
 
When to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment StudyWhen to Conduct a Renal Impairment Study
When to Conduct a Renal Impairment Study
 
Cystitis
CystitisCystitis
Cystitis
 
Endodontic Emergencies
Endodontic  EmergenciesEndodontic  Emergencies
Endodontic Emergencies
 
Smokeless Tobacco & Oral Cancer New
Smokeless Tobacco & Oral Cancer  NewSmokeless Tobacco & Oral Cancer  New
Smokeless Tobacco & Oral Cancer New
 
Postoperative Complications
Postoperative ComplicationsPostoperative Complications
Postoperative Complications
 
pre prosthetic mouth preparation
pre prosthetic mouth preparationpre prosthetic mouth preparation
pre prosthetic mouth preparation
 
Antiarrythmics
AntiarrythmicsAntiarrythmics
Antiarrythmics
 
anchorage in orthodontics
anchorage in orthodonticsanchorage in orthodontics
anchorage in orthodontics
 
orofacial pain
orofacial painorofacial pain
orofacial pain
 
salivary gland diseases
salivary gland diseasessalivary gland diseases
salivary gland diseases
 
Sedative-Hypnotic Drugs
Sedative-Hypnotic DrugsSedative-Hypnotic Drugs
Sedative-Hypnotic Drugs
 
Classification Of Dental Caries
Classification Of Dental CariesClassification Of Dental Caries
Classification Of Dental Caries
 

Similar a meningitis

Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
European School of Oncology
 
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
European School of Oncology
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
Phil Boehmer
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
Phil Boehmer
 

Similar a meningitis (20)

Diagnostic_Dossier_December_2014_HE
Diagnostic_Dossier_December_2014_HEDiagnostic_Dossier_December_2014_HE
Diagnostic_Dossier_December_2014_HE
 
Early HIV Intervention by Dr. Rachel Baden
Early HIV Intervention by Dr. Rachel BadenEarly HIV Intervention by Dr. Rachel Baden
Early HIV Intervention by Dr. Rachel Baden
 
Depersonalising medicine
Depersonalising medicineDepersonalising medicine
Depersonalising medicine
 
Wesat2003
Wesat2003Wesat2003
Wesat2003
 
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
 
Antimicrobial stewardship ppt.pptx
Antimicrobial stewardship ppt.pptxAntimicrobial stewardship ppt.pptx
Antimicrobial stewardship ppt.pptx
 
Patient safety goal 4 : Tackling Antimicrobial Resistance
Patient safety goal 4  : Tackling Antimicrobial ResistancePatient safety goal 4  : Tackling Antimicrobial Resistance
Patient safety goal 4 : Tackling Antimicrobial Resistance
 
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
 
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
 
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
 
1200 j lipman
1200 j lipman1200 j lipman
1200 j lipman
 
Applied Epid
Applied EpidApplied Epid
Applied Epid
 
UAB Pulmonary board review study design and statistical principles
UAB Pulmonary board review study  design and statistical principles UAB Pulmonary board review study  design and statistical principles
UAB Pulmonary board review study design and statistical principles
 
Sepsis JC.pptx
Sepsis JC.pptxSepsis JC.pptx
Sepsis JC.pptx
 
Critical appraisal who solidarity trial interim result on remdesivir
Critical appraisal who solidarity trial interim result on remdesivirCritical appraisal who solidarity trial interim result on remdesivir
Critical appraisal who solidarity trial interim result on remdesivir
 
Critical appraisal who solidarity trial interim result on remdesivir
Critical appraisal who solidarity trial interim result on remdesivirCritical appraisal who solidarity trial interim result on remdesivir
Critical appraisal who solidarity trial interim result on remdesivir
 
nynj-nurse-mod1-09.ppt
nynj-nurse-mod1-09.pptnynj-nurse-mod1-09.ppt
nynj-nurse-mod1-09.ppt
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
 

Más de shabeel pn

Malakkukaludae prarthanakku vidheyamaakunnavar
Malakkukaludae prarthanakku vidheyamaakunnavarMalakkukaludae prarthanakku vidheyamaakunnavar
Malakkukaludae prarthanakku vidheyamaakunnavar
shabeel pn
 
Khaleelullayudae dhanya jeevitham maatrukayaakkunnathu
Khaleelullayudae dhanya jeevitham maatrukayaakkunnathuKhaleelullayudae dhanya jeevitham maatrukayaakkunnathu
Khaleelullayudae dhanya jeevitham maatrukayaakkunnathu
shabeel pn
 
Lailathul qadar
Lailathul qadarLailathul qadar
Lailathul qadar
shabeel pn
 
Prarthana sweeekarikkaathirikkaanulla patthu kaaranangal
Prarthana sweeekarikkaathirikkaanulla patthu kaaranangalPrarthana sweeekarikkaathirikkaanulla patthu kaaranangal
Prarthana sweeekarikkaathirikkaanulla patthu kaaranangal
shabeel pn
 
Islamilae abhivaadyam
Islamilae abhivaadyamIslamilae abhivaadyam
Islamilae abhivaadyam
shabeel pn
 
Visarjana maryaathakal
Visarjana maryaathakalVisarjana maryaathakal
Visarjana maryaathakal
shabeel pn
 
വുളുവിന്റെ രൂപം
വുളുവിന്റെ രൂപം വുളുവിന്റെ രൂപം
വുളുവിന്റെ രൂപം
shabeel pn
 
The golden ages of islamic civilization
The golden ages of islamic civilizationThe golden ages of islamic civilization
The golden ages of islamic civilization
shabeel pn
 
Sunnathintae sthaanam islaamil
Sunnathintae sthaanam islaamilSunnathintae sthaanam islaamil
Sunnathintae sthaanam islaamil
shabeel pn
 
Save your family before they burn
Save your family before they burnSave your family before they burn
Save your family before they burn
shabeel pn
 
Yaatraa maryaathakal
Yaatraa maryaathakalYaatraa maryaathakal
Yaatraa maryaathakal
shabeel pn
 
Urakkam sharddikkenda sunnathukal
Urakkam sharddikkenda sunnathukalUrakkam sharddikkenda sunnathukal
Urakkam sharddikkenda sunnathukal
shabeel pn
 
Pravachakanmaariloodae
Pravachakanmaariloodae Pravachakanmaariloodae
Pravachakanmaariloodae
shabeel pn
 
Namaskarikkunnavar santhoshikkuka
Namaskarikkunnavar santhoshikkukaNamaskarikkunnavar santhoshikkuka
Namaskarikkunnavar santhoshikkuka
shabeel pn
 
Namaskaara sheshamulla dikrukal
Namaskaara sheshamulla dikrukalNamaskaara sheshamulla dikrukal
Namaskaara sheshamulla dikrukal
shabeel pn
 

Más de shabeel pn (20)

meaning of life and faith
meaning of life and faithmeaning of life and faith
meaning of life and faith
 
Swalah of Prophet-Malayalam PDF
Swalah of Prophet-Malayalam PDFSwalah of Prophet-Malayalam PDF
Swalah of Prophet-Malayalam PDF
 
Malayalam 36
Malayalam 36Malayalam 36
Malayalam 36
 
Malayalam 36
Malayalam 36Malayalam 36
Malayalam 36
 
Malakkukaludae prarthanakku vidheyamaakunnavar
Malakkukaludae prarthanakku vidheyamaakunnavarMalakkukaludae prarthanakku vidheyamaakunnavar
Malakkukaludae prarthanakku vidheyamaakunnavar
 
Khaleelullayudae dhanya jeevitham maatrukayaakkunnathu
Khaleelullayudae dhanya jeevitham maatrukayaakkunnathuKhaleelullayudae dhanya jeevitham maatrukayaakkunnathu
Khaleelullayudae dhanya jeevitham maatrukayaakkunnathu
 
Lailathul qadar
Lailathul qadarLailathul qadar
Lailathul qadar
 
Prarthana sweeekarikkaathirikkaanulla patthu kaaranangal
Prarthana sweeekarikkaathirikkaanulla patthu kaaranangalPrarthana sweeekarikkaathirikkaanulla patthu kaaranangal
Prarthana sweeekarikkaathirikkaanulla patthu kaaranangal
 
Islamilae abhivaadyam
Islamilae abhivaadyamIslamilae abhivaadyam
Islamilae abhivaadyam
 
Visarjana maryaathakal
Visarjana maryaathakalVisarjana maryaathakal
Visarjana maryaathakal
 
വുളുവിന്റെ രൂപം
വുളുവിന്റെ രൂപം വുളുവിന്റെ രൂപം
വുളുവിന്റെ രൂപം
 
The golden ages of islamic civilization
The golden ages of islamic civilizationThe golden ages of islamic civilization
The golden ages of islamic civilization
 
Sunnathintae sthaanam islaamil
Sunnathintae sthaanam islaamilSunnathintae sthaanam islaamil
Sunnathintae sthaanam islaamil
 
Save your family before they burn
Save your family before they burnSave your family before they burn
Save your family before they burn
 
Yaatraa maryaathakal
Yaatraa maryaathakalYaatraa maryaathakal
Yaatraa maryaathakal
 
Urakkam sharddikkenda sunnathukal
Urakkam sharddikkenda sunnathukalUrakkam sharddikkenda sunnathukal
Urakkam sharddikkenda sunnathukal
 
Pravachakanmaariloodae
Pravachakanmaariloodae Pravachakanmaariloodae
Pravachakanmaariloodae
 
Namaskarikkunnavar santhoshikkuka
Namaskarikkunnavar santhoshikkukaNamaskarikkunnavar santhoshikkuka
Namaskarikkunnavar santhoshikkuka
 
Namaskaara sheshamulla dikrukal
Namaskaara sheshamulla dikrukalNamaskaara sheshamulla dikrukal
Namaskaara sheshamulla dikrukal
 
Hope..
Hope..Hope..
Hope..
 

Último

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Último (20)

OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
latest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answerslatest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answers
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 

meningitis

  • 1. Issues in Selection of Deltas in Non-Inferiority Trials : Acute Bacterial Meningitis and Hospital-Acquired Pneumonia dr shabeel pn www.hi-dentfinishingschool.blogspot.com
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22. Clinical Trial Implications: Sample size per arm to achieve 80% power 
  • 23. Epidemiology of Meningitis* *Based on 248 cases in 1995 from Schuchat et al. N Engl J Med. 1997;337:970-6.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28. Clinical Trial Implications: Sample size per arm to achieve 80% power 
  • 29.
  • 30.

Notas del editor

  1. Obviously the choice of delta has a big impact on sample size required to provide robust evidence of efficacy. Let’s consider some examples. On the x-axis, we have assumed success rates FOR BOTH ARMS On the y-axis we have the sample size necessary to provide the burden of proof that a desired level of similarity is met with high confidence So when the underlying success rate if 80% for both AC and new -- we would need about 100 pts per arm with a delta of 15, 250 per arm for a delta of 10 and 1000 per arm for a delta of 10% Note that sample size requirements go down as the success rate approaches 100% and increase as the success rate approaches 50%.
  2. Obviously the choice of delta has a big impact on sample size required to provide robust evidence of efficacy. Let’s consider some examples. On the x-axis, we have assumed success rates FOR BOTH ARMS On the y-axis we have the sample size necessary to provide the burden of proof that a desired level of similarity is met with high confidence So when the underlying success rate if 80% for both AC and new -- we would need about 100 pts per arm with a delta of 15, 250 per arm for a delta of 10 and 1000 per arm for a delta of 10% Note that sample size requirements go down as the success rate approaches 100% and increase as the success rate approaches 50%.